
Miss Wu Yanhua
Address:
Floor 4, Building A23, Life Science Industrial Park, No. 140, Jinye Avenue, Sanxi Community, Kuichong Street, Dapeng New District Shenzhen, Shenzhen, Guangdong, China
Telephone:
Zip Code:
Fax:
Please sign in to view contact details |
Account Registered in:
2023
Business Range:
Chemicals, Health & Medicine, Light Industry & Daily Use
Management System Certification:
ISO 9001
Business Type:
Manufacturer/Factory
Company Introduction
Production Capacity
LV Biotech is a technology-oriented enterprise specializing in primary cells separation, frozen storage and regeneration in China. It has obtained the national high-tech enterprise, Biosafety Second-level laboratory, ISO9001 quality management system, GB/T29490-2013 intellectual property standards and other qualifications.
After years of dedicated research and development, the company has ...
After years of dedicated research and development, the company has ...
LV Biotech is a technology-oriented enterprise specializing in primary cells separation, frozen storage and regeneration in China. It has obtained the national high-tech enterprise, Biosafety Second-level laboratory, ISO9001 quality management system, GB/T29490-2013 intellectual property standards and other qualifications.
After years of dedicated research and development, the company has successfully conquered primary hepatocyte isolation, cryopreservation and recovery technology.
The company is transforming previous research results, aiming at advanced liver failure diseases, focusing on new precision medicine technologies in the future, and developing new products and technologies such as allogeneic liver cell transplantation, regenerative liver cell transplantation, artificial liver, etc., to meet the major clinical needs of Shenzhen and even the whole world. It will also explore a broader space for the stable source of samples from the primary hepatocyte bank, the sharing of human heritage resources and the value of samples for scientific research.
After years of dedicated research and development, the company has successfully conquered primary hepatocyte isolation, cryopreservation and recovery technology.
The company is transforming previous research results, aiming at advanced liver failure diseases, focusing on new precision medicine technologies in the future, and developing new products and technologies such as allogeneic liver cell transplantation, regenerative liver cell transplantation, artificial liver, etc., to meet the major clinical needs of Shenzhen and even the whole world. It will also explore a broader space for the stable source of samples from the primary hepatocyte bank, the sharing of human heritage resources and the value of samples for scientific research.
Factory Address:
Floor 4, Building A23, Life Science Industrial Park, No. 140, Jinye Avenue, Sanxi Community, Kuichong Street, Dapeng New District Shenzhen, Shenzhen, Guangdong, China